Randomized clinical trial: 2 fingolimod doses vs. Copaxone for patients with RRMS on: August 25, 2020, 09:15:13 pm #1 From JAMA (August 24, 2020)--"Efficacy and safety of 2 fingolimod doses vs. glatiramer acetate for the treatment of patients with relapsing-remitting multiple sclerosis: A randomized clinical trial":https://bit.ly/3ldtkSB Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
